KAITLYNN WILLIAMS: Open Payments
NPI 1649885252 · FAYETTEVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$956 in 42 payments from 12 companies in 2025. Trend: 2023 $342 · 2024 $295 · 2025 $956
Food & beverage: $956
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 14 | $222 |
| CVRx, Inc. | 1 | $190 |
| Novartis Pharmaceuticals Corporation | 13 | $175 |
| Abbott Laboratories | 2 | $165 |
| Alnylam Pharmaceuticals Inc. | 4 | $73 |
| Regeneron Healthcare Solutions, Inc. | 2 | $34 |
| Medtronic, Inc. | 1 | $24 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
| Philips North America LLC | 1 | $16 |
| Amgen Inc. | 1 | $15 |
Products named: VYNDAQEL, Barostim Neo System, ESPRIT, LEQVIO, AMVUTTRA, ELIQUIS, EVKEEZA, COREVALVE EVOLUT R.
Industry payments across AR — which companies pay providers there.
